TED Initiative Receives Recognition Letter of Research Importance from FDA’s CDRH

The TED Initiative is pleased to announce receipt of the first FDA Center for Devices and Radiologic Health (CDRH) Recognition of Research Importance Letter regarding TBI. This letter, under the signature of Jeffrey Shuren, MD, JD, Director of CDRH, demonstrates FDA’s acknowledgment and commitment to our field. It is signal recognition of the importance and value FDA specifically places on TED’s collaborative work with the NINDS-funded TRACK-TBI investigators and our public and private partners, to advance validation of clinical outcome assessments, neuroimaging biomarkers, and blood-based biomarker endpoints for TBI. To view the letter, click here